Business Context and Reporting Period
Cemtrex Inc. (CETX), a Delaware corporation listed on the Nasdaq Capital Market, filed this Form 8-K on February 21, 2025. The filing addresses a regulatory notification received on the same date regarding the company's compliance with Nasdaq listing standards.
Key Financial Metrics
The filing references financial data from the Form 10-Q for the period ended December 31, 2024, specifically noting that the company's stockholder's equity was below $2,500,000. The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity beyond this equity threshold.
Material Changes
The primary material event is the receipt of a notification from Nasdaq stating that the company no longer meets the Minimum Stockholder's Equity Requirement under Marketplace Rule 5550(b)(1). This deficiency is based on the reported equity position as of December 31, 2024.
Outlook, Risks, and Management Commentary
- Compliance Timeline: The company has 45 calendar days (until April 7, 2025) to submit a plan to regain compliance. If accepted, Nasdaq may grant an extension of up to 180 calendar days (until August 20, 2025) to evidence compliance.
- Management Action: Management is currently working on a plan to regain compliance with the Minimum Stockholder's Equity Requirement and is also taking action to meet the Minimum Bid Price Requirement.
- Risks: There is no guarantee that the company will be able to regain compliance with either requirement or that its plan will be accepted by Nasdaq. Failure to comply could result in delisting.
- Immediate Effect: The notification has no immediate effect on the listing of the company's common stock.
Investor Verification Checklist
- Verify the exact stockholder's equity figure reported in the Form 10-Q for the period ended December 31, 2024.
- Monitor the company's submission of a compliance plan to Nasdaq by the April 7, 2025 deadline.
- Track the company's stock price to assess progress toward the Minimum Bid Price Requirement.
- Review any subsequent filings regarding the acceptance or rejection of the compliance plan by Nasdaq.